GRAL
GRAL
NASDAQ · Biotechnology

Grail Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$48.65
-0.48 (-0.98%)
As of Mar 24, 9:57 PM ET ·
Analyst Consensus
Buy
12
Analysts
Moderate
Coverage
Buy 8 67%
Hold 4 33%
Sell 0 0%
Price Target
Analyst Price Target -31.0% upside
Low Target $28.45
Average Target $33.59
High Target $56.21
Current Price $48.65
Current
$48.65
Target
$33.59
$28.45 $33.59 avg $56.21
Scenario Analysis
Bear Case
$28.45
-41.5%
Low target
Base Case
$33.59
-31.0%
Avg target
Bull Case
$56.21
+15.5%
High target
Risk/Reward
0.4x
Unfavorable
Price in Context
52-Week High
$118.84
-59.1% from high
52-Week Low
$20.44
+138.0% from low
50-Day SMA
$97.75
-50.2% vs SMA
200-Day SMA
$64.49
-24.6% vs SMA
RSI (14)
50.6
Neutral
Target vs 52W High
$33.59
-71.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +25.5%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -45.2%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.6%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -2.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -66.8%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 +3.1%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -26.5%